Loading
Latest filing published 03 Mar 2026 for Lexicon Pharmaceuticals, INC., €255k.
No signal scores available.
This profile gathers the share dealings of Michael Exton in Lexicon Pharmaceuticals, Inc. Activity is concentrated on a single trading day, 28 February 2026, with 2 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 3 March 2026 came the latest disclosure, a share grant for €255k in Lexicon Pharmaceuticals, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations